In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 21st, 2011 | 45 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 6.83 | 15.43 | -21.37 | 0 | 7 | 0 | 71 | 607.636 | 5 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MRCKA-1-E | Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10000 | 0.16 | Binding ≤ 10μM |
MTOR-2-E | Serine/threonine-protein Kinase MTOR (cluster #2 Of 3), Eukaryotic | Eukaryotes | 2 | 0.27 | Binding ≤ 10μM |
P3C2A-1-E | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Subunit Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 176 | 0.21 | Binding ≤ 10μM |
P3C2B-1-E | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Beta Polypeptide (cluster #1 Of 1), Eukaryotic | Eukaryotes | 549 | 0.19 | Binding ≤ 10μM |
P85A-2-E | PI3-kinase P85-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 564 | 0.19 | Binding ≤ 10μM |
PI4KB-1-E | PI4-kinase Beta Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6680 | 0.16 | Binding ≤ 10μM |
PK3C3-1-E | Phosphatidylinositol 3-kinase Catalytic Subunit Type 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 533 | 0.20 | Binding ≤ 10μM |
PK3CA-2-E | PI3-kinase P110-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 250 | 0.21 | Binding ≤ 10μM |
PK3CD-2-E | PI3-kinase P110-delta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 564 | 0.19 | Binding ≤ 10μM |
PK3CG-2-E | PI3-kinase P110-gamma Subunit (cluster #2 Of 3), Eukaryotic | Eukaryotes | 171 | 0.21 | Binding ≤ 10μM |
PRKDC-1-E | DNA-dependent Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.26 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PRKDC_HUMAN | P78527 | DNA-dependent Protein Kinase, Human | 6.34 | 0.26 | Binding ≤ 1μM |
MTOR_HUMAN | P42345 | FK506 Binding Protein 12, Human | 0.29 | 0.30 | Binding ≤ 1μM |
PK3C3_HUMAN | Q8NEB9 | Phosphatidylinositol 3-kinase Catalytic Subunit Type 3, Human | 533 | 0.20 | Binding ≤ 1μM |
P3C2B_HUMAN | O00750 | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Beta Polypeptide, Human | 549 | 0.19 | Binding ≤ 1μM |
P3C2A_HUMAN | O00443 | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Subunit Alpha, Human | 176 | 0.21 | Binding ≤ 1μM |
PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 23 | 0.24 | Binding ≤ 1μM |
PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 564 | 0.19 | Binding ≤ 1μM |
PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 171 | 0.21 | Binding ≤ 1μM |
P85A_HUMAN | P27986 | PI3-kinase P85-alpha Subunit, Human | 250 | 0.21 | Binding ≤ 1μM |
MTOR_MOUSE | Q9JLN9 | Serine/threonine-protein Kinase MTOR, Mouse | 2 | 0.27 | Binding ≤ 1μM |
PRKDC_HUMAN | P78527 | DNA-dependent Protein Kinase, Human | 6.34 | 0.26 | Binding ≤ 10μM |
MTOR_HUMAN | P42345 | FK506 Binding Protein 12, Human | 0.29 | 0.30 | Binding ≤ 10μM |
PK3C3_HUMAN | Q8NEB9 | Phosphatidylinositol 3-kinase Catalytic Subunit Type 3, Human | 533 | 0.20 | Binding ≤ 10μM |
P3C2B_HUMAN | O00750 | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Beta Polypeptide, Human | 549 | 0.19 | Binding ≤ 10μM |
P3C2A_HUMAN | O00443 | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Subunit Alpha, Human | 176 | 0.21 | Binding ≤ 10μM |
PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 1800 | 0.18 | Binding ≤ 10μM |
PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 564 | 0.19 | Binding ≤ 10μM |
PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 171 | 0.21 | Binding ≤ 10μM |
P85A_HUMAN | P27986 | PI3-kinase P85-alpha Subunit, Human | 250 | 0.21 | Binding ≤ 10μM |
PI4KB_HUMAN | Q9UBF8 | PI4-kinase Beta Subunit, Human | 6680 | 0.16 | Binding ≤ 10μM |
MRCKA_HUMAN | Q5VT25 | Serine/threonine-protein Kinase MRCK-A, Human | 10000 | 0.16 | Binding ≤ 10μM |
MTOR_MOUSE | Q9JLN9 | Serine/threonine-protein Kinase MTOR, Mouse | 2 | 0.27 | Binding ≤ 10μM |
Description | Species |
---|---|
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
Costimulation by the CD28 family | |
Cytosolic sensors of pathogen-associated DNA | |
DAP12 signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
G alpha (12/13) signalling events | |
G alpha (q) signalling events | |
G beta:gamma signalling through PI3Kgamma | |
GAB1 signalosome | |
Golgi Associated Vesicle Biogenesis | |
GP1b-IX-V activation signalling | |
GPVI-mediated activation cascade | |
HSF1-dependent transactivation | |
Interleukin receptor SHC signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
Interleukin-7 signaling | |
IRF3-mediated induction of type I IFN | |
mTOR signalling | |
Nephrin interactions | |
Nonhomologous End-joining (NHEJ) | |
PI-3K cascade | |
PI3K Cascade | |
PI3K events in ERBB2 signaling | |
PI3K events in ERBB4 signaling | |
PI3K/AKT activation | |
PIP3 activates AKT signaling | |
Processing of DNA ends prior to end rejoining | |
Regulation of signaling by CBL | |
Release of eIF4E | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Role of phospholipids in phagocytosis | |
S6K1-mediated signalling | |
Signaling by constitutively active EGFR | |
Signaling by FGFR mutants | |
Signaling by FGFR1 fusion mutants | |
Signaling by SCF-KIT | |
Synthesis of PIPs at the early endosome membrane | |
Synthesis of PIPs at the Golgi membrane | |
Synthesis of PIPs at the late endosome membrane | |
Synthesis of PIPs at the plasma membrane | |
Tie2 Signaling | |
Toll Like Receptor 9 (TLR9) Cascade | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated vascular permeability |
No pre-computed analogs available. Try a structural similarity search.